1. S. Cokmert, L. Demir, A. A. Sari, Y. Kucukzeybek, A. Can,M. Akyol, I. V.Bayoglu, A. Dirican, C. Erten,M. O. Tarhan, "Synchronous Appearance of a High-Grade Neuroendocrine Carcinoma

2. L. Demir, N. Ekinci, Ç.Erten, I. Somalı, A.Can, A. Dirican, S. Çokmert, V. Bayoglu, M. Akyol, Y. Küçükzeybek, A.Alacaıoglu, M.O. Tarhan, "The Impact of Cell Proliferation Markers and p53

3. S. Cokmert, L. Demir, M. Akyol, I.V. Bayoglu, A. Can, I.T. Unek, F.A. Bolat, "Clitoris metastasis from a retroperitoneal leiomyosarcoma: A case report", World Journal of Clinical

4. L. Demir, N. Ekinci, Ç. Erten, Y.Küçükzeybek, A. Alacacioglu, I. Somali, A. Can, A. Dirican, V. Bayoglu, M. Akyol, F. Çakalagaoglu, M. O. Tarhan, "Does Immunohistochemistry Provide

5. Ç. Erten, L. Demir, I. Somali, A. Alacacioglu, Y. Kücükzeybek, M. Akyol, A. Can, A.Dirican, V. Bayoglu, M. O. Tarhan, "Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with…

6. L. Demir, S. Yigit, H. Ellidokuz, Ç. Erten, I. Somali, Y. Küçükzeybek, A. Alacacioglu, S. Çokmert, A. Can, M. Akyol, A. Dirican, V. Bayoglu, A. A. Sari, M. O. Tarhan, "Predictive and…

7. A. Dirican, Y. Kucukzeybek , I. Somali, C. Erten, L. Demir, A. Can, K. B. Payzin, I. V. Bayoglu, M. Akyol, M. Koseoglu, A. Alacacioglu, M. O. Tarhan, "The association of hematologic

8. A. Can, A. Alacacioglu, Y. Kucukzeybek, C. Erten, S. Cokmert, L. Demir, A. Dirican, I. V. Bayoglu, M.Akyol, F. Aslan, M. O. Tarhan, "The relationship of insulin resistance and metabolic

9. A. Dirican, Y. Kucukzeybek, Ç. Erten, I.Somali, L.Demir, A. Can, K. B. Payzın, I. V.Bayoglu, M. Akyol,Y. Yildiz, M. Köseoglu, A. Alacacıoglu, M. O.Tarhan, "Prognostic and Predictive Value of

10. L. Demir, Ç. Erten, I. Somali, A. Can, A. Dirican, V. Bayoglu,Y. Kucukzeybek, A. A. Altınboga, M. Ermete, R. M. Oztop, M.O. Tarhan , "Metastases of renal cell carcinoma to the

11. Y. Kucukzeybek, A. Dirican, Ç. Erten, I. Somali, A.Can, L. Demir, I. V. Bayoglu, M. Akyol, M. Medeni, M. O. Tarhan, "Second-Line Irinotecan after Cisplatin, Fluoropyrimidin and Docetaxel

12. M. O. Tarhan, L. Demir, I. Somali, S. Yigit, Ç. Erten, A. Alacacioglu, H. Ellidokuz, Ö. Seseogullari, Y.Kucukzeybek, A. Can, A. Dirican, V. Bayoglu, M. Akyol, "The clinicopathological

13. L. Demir, A. Can, A. Dirican, V. Bayoglu,T. A. Rezanko, M. Akyol, Y. Kucukzeybek, Ç.Erten, M. O. Tarhan, "Malignant Fibrous Histiocytoma of the Spermatic Cord in a Patient With Polycystic

14. A. Dirican, Y. Küçükzeybek, I. Somalı, Ç. Erten, L. Demir, A. Can, I. V. Bayoglu, M. Ermete, A. A. AltInboga, M. O. Tarhan, "Cutaneous and subcutaneous metastases from bladder

15. L. Demir, Ç. Erten, S. Ç. Yigit, A. Can, A. Dirican, V. Bayoglu, Y. Kucukzeybek, I. Somali, M.O. Tarhan, "Intramammary lymph node metastasis in a patient with ovarian carcinoma and a

16. K. Bayan, S. Yılmaz, Y. Tüzün,A. Can, H.Büyükbayram, "Granular cell tumor of the esophagus and its endoscopic treatment", Turk J Gastroenterol , "18 (3", 208-209 pp., Mart-

17. A. Dirican, Y. Kucukzeybek, M. O. Tarhan, I. Somali, Ç. Erten, L. Demir, A. Can, I. V. Bayoglu, M. Akyol, N. Ekinci, M. Medeni, B. Koyuncu,A. Alacacioglu, "One-day DCF regimen in

18. A. Dirican,, N. Ekinci, A. Avci, M. Akyol, A. Alacacioglu, Y. Kucukzeybek, I. Somali, Ç Erten, L. Demir, A. Can, I. V. Bayoglu, B. Koyuncu, E. Ulger, M. O. Tarhan, "The effects of hematological

19. L.Demir, A. Can, R. Oztop1, A. Dirican, V. Bayoglu, M. Akyol, Y.Kucukzeybek, Ç. Erten, I. Somali, M. O.Tarhan, "Malignant epithelioid hemangioendothelioma progressing after

20. Lutfiye Demir, M. Akyol, S. Bener, K. B. Payzin,Ç. Erten, I. Somali, A. Can, A.Dirican,V. Bayoglu, Y. Kucukzeybek, A. Alacacioglu, A. O. Calli, M. O. Tarhan, "Prognostic Evaluation of

21. S. Cokmert, L. Demir, A. Can, Murat Akyol, I. V. Bayoglu, A. Dirican, Y. Kucukzeybek, Ç. Erten, M. O. Tarhan, "Capecitabine-related increased mean corpuscular volume of red blood cell

22. L. Demir, I. Somali, M. O. Tarhan, C. Erten, H. Ellidokuz, A. Can, A. Dirican,I. Vedat Bayoglu, "The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III

23. A. Dirican, Y. Kucukzeybek, , I. Somali, Ç. Erten, L. Demir, A. Can. Micro-metastates into the uterine leiomyoma from invasive ductal breast cancerunder adjuvan tamoxifen therapy.

24. Alper Can, Erkan Dogan, Ibrahim Vedat Bayoglu, Ali Murat Tatli, Mehmet Besiroglu, Murat Kocer.. Multicenter Epidemiologic Study on Hepatocellular Carcinoma in Turkey

25. Ahmet Dirican, Umut Varol, Yuksel Kucukzeybek, Ahmet Alacacioglu, Cigdem Erten, Isil Somali, Alper Can.. Treatment of Metastatic Colorectal Cancer With or Without Bevacizumab: Can the Neutrophil/Lymphocyte Ratio Predict the Efficiency of Bevacizumab?

26. Murat Akyol, Umut Varol, Ibrahim Yildiz, Ibrahim Vedat Bayoglu, Yasar Yildiz, Lutfiye Demir, Ahmet Dirican, Alper Can.. Isolated Liver Metastasis of Sacrococcygeal Chordoma: Case Report and Review of the Literature.

27. Ahmet Dirican, Yuksel Kucukzeybek, Cigdem Erten, Isil Somali, Alper Can... Cardiac rhabdomyosarcoma of the left atrium

28. Can A., Aslan F, Alacacıoglu A , Kucukzeybek Y , Erten C., Çokmert S , Demir L , Dirican A, Bayoglu IV , Akyol M and Tarhan MO. The Prognostic Value of the Metabolic Syndrome in Colon Cancer Patients.

29. Şehmus Ölmez, Alper Can., Alpaslan Yavuz, Umut Haluk iliklerden, Gülay B., Esophageal Lymphoepithelioma-Like Carcinoma with Unique Daisy-Like Appearance

30. S.Cokmert, Ö. Tanrıverdi, I. Karapolat, L.Demir, V.Bayoğlu, Alper Can.Zerbinis Medical Publ.

31.Mutlu Hizal, Burak Bilgin, Nail Paksoy, Özgür Açıkgöz, Ahmet Sezer, Mustafa Gürbüz, Naziye Ak, Şebnem Yücel, Murat Ayhan, Cihan Erol, Aykut Demirkıran, Nil Molinas Mandel, Abdallah Shbair, İvo Gökmen, Tuğba Başoğlu, Semra Paydaş, Atike Gökçen Demiray, Yakup İriağaç, Teoman Şakalar, Esra Zeynelgil, Ali Murat Tatlı, Aykut Bahçeci, Deniz Can Güven, Burcu Caner, Alper Can, Ahmet Gülmez, Yusuf Karakaş, Bülent Yalçın, Ahmet Demirkazık, Ahmet Bilici, Adnan Aydıner, Perran Fulden Yumuk, Mehmet Ali Nahit Şendur The Real-Life Efficacy And Safety of Osimertinib In Pretreated Advanced Non-Small Cell Lung Cancer Patients With T790M Mutation: A Turkish Oncology Group Study , 2021 The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.